| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
189,880,000 |
| Market
Cap: |
9.74(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$22.35 - $51.18 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
4,188,322 |
16,611,414 |
26,208,119 |
26,480,251 |
| Total Sell Value |
$184,055,015 |
$602,108,475 |
$884,190,693 |
$893,481,786 |
| Total People Sold |
7 |
10 |
10 |
11 |
| Total Sell Transactions |
15 |
28 |
37 |
52 |
| End Date |
2025-05-18 |
2025-02-14 |
2024-08-16 |
2023-08-17 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Homcy Charles J |
|
– • – |
2025-08-11 |
4 |
AS |
$48.00 |
$2,400,000 |
D/D |
(50,000) |
916,674 |
|
- |
|
| Homcy Charles J |
|
– • – |
2025-08-08 |
4 |
AS |
$45.87 |
$11,512,443 |
D/D |
(250,000) |
966,674 |
|
- |
|
| Kumar Neil |
Chief Executive Officer |
• • – |
2025-08-08 |
4 |
AS |
$45.88 |
$1,848,828 |
I/I |
(40,000) |
915,686 |
|
- |
|
| Apuli Maricel |
Chief Accounting Officer |
• – – |
2025-08-07 |
4 |
S |
$45.44 |
$45,440 |
D/D |
(1,000) |
141,859 |
|
-11% |
|
| Kumar Neil |
Chief Executive Officer |
• • – |
2025-08-07 |
4 |
AS |
$45.09 |
$1,818,121 |
I/I |
(40,000) |
935,686 |
|
- |
|
| Ellis Andrea |
|
– • – |
2025-08-05 |
4 |
AS |
$49.00 |
$841,183 |
D/D |
(17,167) |
18,589 |
|
-5% |
|
| Ellis Andrea |
|
– • – |
2025-08-05 |
4 |
OE |
$16.75 |
$287,547 |
D/D |
17,167 |
35,756 |
|
- |
|
| Kumar Neil |
Chief Executive Officer |
• • – |
2025-07-02 |
4 |
AS |
$42.73 |
$1,709,050 |
I/I |
(40,000) |
955,686 |
|
9% |
|
| Kumar Neil |
Chief Executive Officer |
• • – |
2025-07-01 |
4 |
AS |
$42.50 |
$1,701,400 |
I/I |
(40,000) |
975,686 |
|
9% |
|
| Shabet Rose Sharon |
|
• • • |
2025-06-27 |
4 |
S |
$44.00 |
$154,000,000 |
I/I |
(3,500,000) |
18,555,375 |
|
-14% |
|
| Homcy Charles J |
|
– • – |
2025-06-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
20,000 |
1,216,674 |
|
- |
|
| Valantine Hannah |
|
– • – |
2025-06-26 |
4 |
S |
$44.03 |
$100,824 |
I/I |
(2,289) |
398 |
|
-13% |
|
| Valantine Hannah |
|
– • – |
2025-06-26 |
4 |
S |
$44.01 |
$106,504 |
D/D |
(2,418) |
7,465 |
|
-13% |
|
| Mccormick Frank |
|
– • – |
2025-06-24 |
4 |
AS |
$44.23 |
$4,422,800 |
I/I |
(100,000) |
879,979 |
|
5% |
|
| Valantine Hannah |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
8,353 |
|
- |
|
| Lo Andrew |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
54,688 |
|
- |
|
| Dachille Douglas A. |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
6,589 |
|
- |
|
| Homcy Charles J |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
1,236,674 |
|
- |
|
| Momtazee James C |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
95,080 |
|
- |
|
| Aguiar Eric |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
6,589 |
|
- |
|
| Satvat Ali J. |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
165,993 |
|
- |
|
| Ellis Andrea |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
18,589 |
|
- |
|
| Hassan Fred |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
25,889 |
|
- |
|
| Daniels Ronald J |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
16,991 |
|
- |
|
| Mccormick Frank |
|
– • – |
2025-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
6,589 |
83 |
|
- |
|
387 Records found
|
|
Page 1 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.14 (0.27%) 
